Professional Documents
Culture Documents
To The Shareholders of
Beximco Pharmaceuticals Limited
Auditors Responsibility
Our responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with
International Standards on Auditing (ISA) and Bangladesh Standards on Auditing (BSA). Those standards require that we comply with
ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free
from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements.
The procedures selected depend on our judgment, including the assessment of the risks of material misstatement of the financial
statements, whether due to fraud or error. In making those risk assessments, we consider internal control relevant to the entitys
preparation and fair presentation of the financial statements in order to design audit procedure that are appropriate in the circumstance,
but not for the purpose of expressing an opinion on the effectiveness of the entitys internal control. An audit also includes evaluating
the appropriateness of accounting policies used and the reasonableness of accounting estimates made by management, as well as
evaluating the overall presentation of the financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Opinion
In our opinion, the financial statements give a true and fair view of the financial position of the Company as at 30 June 2016, and of its
financial performance and its cash flows for the period of 18 months then ended in accordance with International Financial Reporting
Standards (IFRSs) and Bangladesh Financial Reporting Standards (BFRSs), the Companies Act 1994, the Securities and Exchange Rules
1987 and other applicable laws and regulations.
Other matter
Financial Statements of the Company for the year ended 31 December 2015 and period ended 30 June 2016 have separately been
audited by us. Now the Company is required to follow accounting year as July to June as per Finance Act 2015. For this purpose,
separately audited financial statements have been compiled as per directives of The Bangladesh Securities and Exchange Commission
(BSEC).
(a) we have obtained all the information and explanations which to the best of our knowledge and belief were necessary for the
purposes of our audit and made due verification thereof;
(b) in our opinion, proper books of account as required by law have been kept by the company so far as it appeared from our
examination of these books;
(c) the Statement of Financial Position ( Balance Sheet) and Statement of Profit or Loss and other Comprehensive Income (Profit and
Loss Account) dealt with by the report are in agreement with the books of account; and
(d) the expenditure incurred was for the purposes of the companys business.
Page 1
Audit Report 2016 I 1
Beximco Pharmaceuticals Limited
Statement of Financial Position
As at June 30, 2016
Amount in Taka
Dhaka M. J. Abedin & Co.
6 October, 2016 Chartered Accountants
2Page
I Audit
2 Report 2016
Beximco Pharmaceuticals Limited
Statement of Profit or Loss and Other Comprehensive Income
For 18 Months Period ended 30th June 2016
Amount in Taka
Salman F Rahman
Nazmul Hassan Ali Nawaz
Vice Chairman Managing Director
Chief Financial Officer
Per our report of even date.
Dhaka M. J. Abedin & Co.
6 October, 2016 Chartered Accountants
Page 4
Beximco Pharmaceuticals Limited
Statement of Cash Flows
For 18 Months Period ended 30th June 2016
Amount in Taka
January 2015 - January -
June 2016 December 2014
(18 Months) (12 Months)
Cash Flows from Operating Activities :
Receipts from Customers and Others 19,756,621,890 11,085,037,894
Payments to Suppliers and Employees (15,204,763,705) (8,240,584,352)
Cash Generated from Operations 4,551,858,185 2,844,453,542
Interest Paid (1,030,182,401) (724,314,963)
Interest Received 404,847,333 489,970,647
Income Tax Paid (757,245,805) (394,128,824)
Net Cash Generated from Operating Activities 3,169,277,312 2,215,980,402
Page 5
M. J. Abedin & Co. CONTINUATION SHEET
1. Reporting entity
The registered office of the company is located at House No. 17, Road No. 2, Dhanmondi R/A, Dhaka. The industrial units
are located at Tongi and Kaliakoir of Gazipur district vicinities close to the capital city Dhaka.
Therefore, the financial statements for the period of 18 months (01.01.2015 to 30.06.2016) are not entirely comparable
with the comparative of 12 months (01.01.2014 to 31.12.2014).
Page 6
6 I Audit Report 2016
M. J. Abedin & Co. CONTINUATION SHEET
Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis.
Any revision of accounting estimates are recognized in the period in which the estimate is revised and in any future
periods affected.
In particular, the key areas of estimation, uncertainty and critical judgments in applying accounting policies that have the
most significant effect on the amounts recognized in the financial statements include depreciation, inventory valuation,
accrued expenses, others payable and deferred liability for gratuity.
Cash dividend income on investment in shares is recognized on approval of said dividend in the annual general meeting.
Stock dividend income (Bonus Shares) is not considered as revenue.
3.2.3 Depreciation
Depreciation is provided to amortise the cost of the assets after commissioning, over the period of their expected useful
lives, in accordance with the provisions of IAS 16: Property, Plant and Equipment. Depreciation is provided at the following
rates on reducing balance basis:
Page 7
Audit Report 2016 I 7
M. J. Abedin & Co. CONTINUATION SHEET
3.6 Impairment
(a) Financial Assets
Accounts receivable and other receivables are assessed at each reporting date to determine whether there is any
objective evidence of impairment. Financial assets are impaired if objective evidence indicates that a loss event has
occurred after the initial recognition of the asset and that the loss event had a negative effects on the estimated future
cash flows of that asset, that can be estimated reliably. Objective evidence that financial assets are impaired can include
default or delinquency by a debtor, indications that a debtor or issuer will enter bankruptcy etc.
Page 8
8 I Audit Report 2016
M. J. Abedin & Co. CONTINUATION SHEET
3.7 Inventories
Inventories are carried at the lower of cost and net realizable value as prescribed by IAS 2: Inventories. Cost is determined
on weighted average cost basis. The cost of inventories comprises of expenditure incurred in the normal course of
business in bringing the inventories to their present location and condition. Net realizable value is based on estimated
selling price less any further costs expected to be incurred to make the sale.
3.8 Provisions
A provision is recognized in the statement of financial position when the company has a legal or constructive obligation
as a result of a past event, it is probable that an outflow of economic benefits will be required to settle the obligation and
a reliable estimate can be made of the amount of the obligation. Provision is ordinarily measured at the best estimate of
the expenditure required to settle the present obligation at the date of statement of financial position. Where the effect of
time value of money is material, the amount of provision is measured at the present value of the expenditures expected
to be required to settle the obligation.
Current Tax
Current tax is the expected tax payable on the taxable income for the period, and any adjustment to tax payable in
respect of previous years. The company qualifies as a Publicly Traded Company; hence the applicable Tax Rate is
25%.
Deferred Tax
The company has recognized deferred tax using balance sheet method in compliance with the provisions of IAS 12:
Income Taxes. The companys policy of recognition of deferred tax assets/ liabilities is based on temporary differences
(Taxable or deductible) between the carrying amount (Book value) of assets and liabilities for financial reporting purpose
and its tax base, and accordingly, deferred tax income/expenses has been considered to determine net profit after tax
and earnings per shares (EPS).
A deferred tax asset is recognized to the extent that it is probable that future taxable profit will be available, against
which temporary differences can be utilized. Deferred tax assets are reviewed at each reporting date and reduced to
the extent that it is no longer probable that the related tax benefit will be realized.
The company has accounted for and disclosed employee benefits in compliance with the provisions of IAS 19: Employee
Benefits.
The cost of employee benefits is charged off as revenue expenditure in the period to which the contributions relate.
Page 9
Audit Report 2016 I 9
M. J. Abedin & Co. CONTINUATION SHEET
The company has a registered provident fund scheme (Defined Contribution Plan) for employees of the company eligible
to be members of the fund in accordance with the rules of the provident fund constituted under an irrevocable trust. All
permanent employees contribute 10% of their basic salary to the provident fund and the company also makes equal
contribution.
The company recognizes contribution to defined contribution plan as an expense when an employee has rendered
services in exchange for such contribution. The legal and constructive obligation is limited to the amount it agrees to
contribute to the fund.
This represents unfunded gratuity scheme for its permanent employees. Employees are entitled to gratuity benefit after
completion of minimum five years of service in the company.
Though no valuation was done to quantify actuarial liabilities as per the IAS 19: Employee Benefits, such valuation in not
likely to yield a result significantly different from the current provision.
Short-term employee benefits include salaries, bonuses, leave encashment, etc. Obligations for such benefits are
measured on an undiscounted basis and are expensed as the related service is provided.
This represents 5% of net profit before tax contributed by the company as per provisions of the Bangladesh Labor
(amendment) Act 2013 and is payable to workers as defined in the said law.
Page 10
The Bonus Shares issued during the year 2014 were treated as if they always had been in issue. Hence, in computing
the Basic EPS of Current Period (January 2015 to June 2016), the total number of shares including the said bonus shares
has been considered as the Weighted Average Number of Shares outstanding during the Current Period (January 2015
to June 2016).
The number of shares outstanding before the bonus issue has been adjusted for the proportionate change in the number
of shares outstanding as if the bonus issue had occurred at the beginning of the earliest period reported (2014), and
accordingly, in calculating the adjusted EPS of 2014, the total number of shares including the subsequent bonus issued
in 2015 has been considered as the Weighted Average number of Shares outstanding during the year 2014.
The basis of computation of number of shares as stated above is in line with the provisions of IAS 33: Earning per Share.
The logic behind this basis, as stated in the said IAS is that the bonus Shares are issued to the existing shareholders
without any consideration, and therefore, the number of shares outstanding is increased without an increase in
resources.
No diluted EPS is required to be calculated for the period as there was no scope for dilution during the period under
review.
The monetary assets and liabilities, if any, denominated in foreign currencies at the financial position date are translated
at the applicable rates of exchanges ruling at that date. Exchange differences are charged off as revenue expenditure
in compliance with the provisions of IAS 21: The Effects of Changes in Foreign Exchange Rates.
Page 11
Assets include leasehold assets of Tk. 1,277,737,554 at cost and Tk.1,053,077,850 at carrying value.
Cost
At January 01, 2014 3,302,882,482 6,370,758,420 10,034,644,242 173,333,992 548,077,240 358,363,316 20,788,059,692
Addition During the Year 40,858,960 39,331,900 111,420,014 24,240,377 59,392,132 31,650,351 306,893,734
Transferred in & Capitalized - - 427,051,445 - - - 427,051,445
Disposal during the year - - - (573,000) (10,623,868) - (11,196,868)
As on 31 December 2014 3,343,741,442 6,410,090,320 10,573,115,701 197,001,369 596,845,504 390,013,667 21,510,808,003
Accumulated Depreciation
At January 01, 2014 - 1,052,546,636 3,090,128,096 69,430,902 237,436,147 237,273,060 4,686,814,841
Depreciation for the year - 163,516,467 492,388,770 10,375,309 61,346,435 18,145,890 745,772,871
Adjustment for Assets disposed off - - - (423,000) (6,714,953) - (7,137,953)
As on 31 December, 2014 - 1,216,063,103 3,582,516,866 79,383,211 292,067,629 255,418,950 5,425,449,759
Page 12
Page 13
9. Accounts Receivable
This includes receivable of Tk. 107,075,699 equivalent to US$ 1,372,765 as on 30 June 2016 (on 31-12-2014 Tk. 136,834,694
equivalent to US $ 1,763,334) against export sales.
This also includes Tk. 1,430,821,670 due from I & I Services Ltd., who provides distribution service to the Company and a
Related Party. The maximum amount due from that company during the period was Tk. 1,430,821,670 on 30 June, 2016.
The receivables on account of Export sales are fully secured against Letter of Credit while the others are unsecured but
considered good.
No amount was due from the directors, managing agent, managers and other officers of the company and any of them severally
or jointly with any other person.
Page 14
(a) The maximum amount due from the employees during the period was Tk. 89,024,168 on 31 May, 2016.
(b) No amount was due from the directors, managing agent, managers and other officers of the company and any of them severally
or jointly with any other person, except as stated above.
(c) No amount was due from any related party.
(d) Prepaid expense includes Tk. 302,987,514 for Insurance premium paid to German Export Credit Agency Euler Hermes
Aktiengesellschaft, Hamburg for gurantee Insurance premium which is an integral part of the overseas loan financing agreement
with BHF-Bank Aktiengesellshaft, Frankfurt, Germany. Part of the premium related to the period of construction of the project shall be
capitalized while the rest shall be charged to expenses over the tenure of the loan.
11. Short Term Investment
This represents the Companys temporary investment with Bangladesh Export Import Company Limited, carrying interest 1% above
bank interest rate. This investment is returnable as and when required by the Company.
12. Cash and Cash Equivalents
This consists of as follows : Amount in Taka
Page 15
51,775,750 shares of Tk. 10/- each fully paid-up in cash 517,757,500 517,757,500
297,226,087 Bonus Shares (2014: 278,833,505) of Tk. 10/- each 2,972,260,870 2,788,335,050
5,951,250 Shares of Tk. 10/- each issued in Exchange of
Shares of Beximco Infusions Ltd. 59,512,500 59,512,500
31,291,147 Shares issued on conversion of Preference Shares 312,911,470 312,911,470
3,862,442,340 3,678,516,520
The movement of Ordinary Shares during the Period ended June 30, 2016 is as follows :
Number of Shares Amount in Taka
Balance as on January 01, 2015 367,851,652 3,678,516,520
Bonus Shares issued during the period (for 2014) 18,392,582 183,925,820
Balance as on June 30, 2016 386,244,234 3,862,442,340
Page 16
Page 17
16. Liability for Gratuity and WPPF & Welfare Funds
Liability for gratuity is the amount payable to the permanent employees at the time of separation from the company. The liability
for WPPF refers to the undistributed portion of Workers Profit Participation and Welfare Fund lying with the company.
Amount in Taka
(a) Gratuity Payable
30 June, 2016 31 December, 2014
Opening Balance at beginning of the period 337,652,786 284,163,669
Provisions during the period 128,134,755 66,915,861
465,787,541 351,079,530
Page 18
(b) Short Term Borrowings from AB Bank, Principal Branch as mentioned above, has subsequently been converted as Long
Term loan payable in 18 quarterly installments commencing from September 2016.
(c) Conversion of Short term loan into long term being a non-cash event, the net Increase/ Decrease in the Short/Long Term
borrowings as reported in the cash flow statement does not include such conversion.
Page 19
Sales represents:
Quantity
Product Category Unit January 2015- January- January - January -
June 2016 June 2016 December 2015 December 2014
(18 Months) (6 Months) (12 Months) (12 Months)
Tablet, Capsule, Suppository & DPI Million pcs. 5,308.62 1,913.93 3,394.69 2,998.47
Liquid, Cream and Ointment,
Suspension, IV Fluid, Amino Acid,
Ophthalmic, Nebulizer Solution,
Injectable and Inhaler Million pcs. 121.46 45.80 75.66 70.72
Diet Care Products Pcs 16,069 10,157 5,912 -
Active Pharmaceutical Ingredients Kg 282,789 113,953 168,836 177,354
Liquid Nitrogen Liter 725,260 241,505 483,755 475,012
Page 20
20 I Audit Report 2016
M. J. Abedin & Co. CONTINUATION SHEET
Item wise quantity and value of Finished Goods Stock are as follows :
Stock as January 01, 2015 Unit Quantity Value (Tk.)
Tablet, Capsule, Suppository & DPI Million pcs. 426.64 389,211,055
Liquid, Cream and Ointment, Suspension, IV Fluid, Amino Acid,
Ophthalmic, Nebulizer Solution, Injectable and Inhaler Million pcs. 6.78 236,895,019
Active Pharmaceutical Ingredients Kg 2,450 7,586,115
633,692,189
Stock as June 30, 2016
Tablet, Capsule, Suppository & DPI Million pcs. 370.24 351,741,050
Liquid, Cream and Ointment, Suspension, IV Fluid, Amino Acid,
Ophthalmic, Nebulizer Solution, Injectable and Inhaler Million pcs. 6.85 257,318,388
Active Pharmaceutical Ingredients Kg 7,029 18,650,439
Diet Care Products Pcs 30,535 12,214,000
639,923,877
(a) Salary and allowances include an amount of Tk.17,859,896 being Companys Contribution to provident fund for the period
January 2015 to June 2016.
(b) The value of imported stores and spares consumed during January 2015 to June 2016 Tk.138,743,197 is included in repairs
& maintenance. This also includes maintenance of office, premises, vehicles, building, machinery, equipment and other
infrastructures.
(c) Other expenses does not include any item exceeding 1% of total revenue.
Page 21
Audit Report 2016 I 21
M. J. Abedin & Co. CONTINUATION SHEET
Amount in Taka
Interest on FDR & Short term Investment 404,847,333 100,525,928 304,321,405 489,970,647
Dividend Income 1,427,955 - 1,427,955 1,427,955
Royalty 10,634,016 - 10,634,016 24,763,177
Exchange Rate Fluctuation Gain / (Loss) (5,406,570) 379,817 (5,786,387) 1,452,991
Profit on Sale of Fixed Assets (Note 35) 1,156,189 74,852 1,081,337 3,556,877
412,658,923 100,980,597 311,678,326 521,171,647
Interest on Working Capital Loan 588,417,111 166,656,402 421,760,709 391,510,508
Interest on Project / Consortium Loan 152,835,514 35,067,043 117,768,471 175,227,715
Interest on Lease Finance 149,565,303 71,030,756 78,534,547 64,812,955
Interest on Loan from PF, WPPF &
Welfare Fund 98,800,975 37,698,000 61,102,975 71,225,739
Other Bank Charges 40,563,498 10,759,966 29,803,532 21,538,046
1,030,182,401 321,212,167 708,970,234 724,314,963
(i) Tax provision for current period 766,053,375 310,173,315 455,880,060 421,487,672
(ii) Short/(Excess) Provision for earlier year (29,913,148) - (29,913,148) 15,295,172
736,140,227 310,173,315 425,966,912 436,782,844
(b) Deferred Tax Expense /
(Income) (26,356,152) 16,765,213 (43,121,365) 144,475,316
709,784,075 326,938,528 382,845,547 581,258,160
(a) Earnings attributable to the
Ordinary Shareholders Tk. 2,948,053,854 993,769,338 1,954,284,516 1,528,297,573
(b) Weighted average number of
Ordinary Shares outstanding
during the period (Note 3.15) Nos. 386,244,234 386,244,234 386,244,234 386,244,234
Earnings Per Share (EPS) /
Adjusted EPS Tk. 7.63 2.57 5.06 3.96
Following transactions were carried out with related parties in the normal course of business on arms length basis:
Name of Related Parties Nature of Transactions Value of Transaction Balance at Period End
(a) I & I Services Ltd. Local Delivery 21,290,407,357 1,430,821,670
Distribution Commission 322,248,539 -
(b) Bangladesh Export Import Co. Ltd. Short Term Investment & Interest there on 1,035,989,018 1,439,037,813
The Companies are subject to common control from same source.
(a) The aggregate amounts paid to/ provided for the Managers and above of the company is disclosed below :
Amount in Taka
January 2015- June 2016
(18 Months)
Remuneration 295,224,430
Gratuity 10,779,325
Contribution to Provident Fund 12,831,690
Bonus 30,545,000
Medical 6,311,696
Others 32,899,347
388,591,488
(b) The above includes salary, allowances, and perquisites amounting Tk. 47,917,879 paid to the Managing Director.
(c) This also includes Tk. 580,000 paid to Independent Directors for attending Board, Audit Committee and other meetings.
(d) Excepting as stated above (c) no board meeting fee was paid to any directors.
(e) No amount of money was expended by the company for compensating any member of the board for special services
rendered.
Production does not include goods manufactured under contract manufacturing arrangement from third partys manufacturing
sites.
Page 24
24 I Audit Report 2016
M. J. Abedin & Co. CONTINUATION SHEET
Companys committed capital expenditure relating to the procurement of Machinery and Equipment as on June 30, 2016 is
US$ 1,706,236.
Page 25
Audit Report 2016 I 25
M. J. Abedin & Co. CONTINUATION SHEET